8840 hospitals have been registered, and drug use monitoring will be carried out in an all-round way

[industry trends of pharmaceutical network] recently, the statistics and information center of the national health and Health Commission announced that since the national drug use monitoring platform was put into operation, 8840 medical and health institutions have completed the system login, with an average daily visit of 600000 people It is reported that the "national drug use monitoring platform" was established on April 9, this year, after the national health and Health Commission officially issued a notice, aiming to accurately grasp the use of drugs in various public medical and health institutions at all levels and promote the priority use of essential drugs By 2020, the monitoring scope will basically cover the public medical institutions at or above the second level, and extend to the grass-roots medical and health institutions, and gradually realize the monitoring of all equipped and used drugs At present, there are new news that more than 10000 medical and health institutions in all three levels, half two levels and some grassroots levels across the country will submit the organization's drug directory, key monitoring rational drug directory, drug in and out, use data and other information through the "national drug use monitoring platform"   In fact, since the Department of drug policy and basic drug system of the national health and Health Commission issued the notice of the national health and Health Commission on the implementation of drug use monitoring and clinical comprehensive evaluation, it is required to carry out drug use monitoring as a whole, and all public medical and health institutions shall cooperate with each other as required to systematically collect and report the types of drugs, production enterprises, quantity of use and procurement Price, supply and distribution information The work of monitoring the use of drugs has been carried out all over the country For example, in Guizhou Province, in a short period of time, the public medical institutions have realized the full coverage of the national drug shortage information direct reporting system, and established the four levels of provincial, municipal, county and township drug shortage monitoring and early warning, as well as the three levels of provincial, municipal and County response and disposal system The number of medical institutions using the national information reporting system for drug shortage increased rapidly from one at the end of January this year to 1848 in April In addition, Shandong Province, in the previously announced "Shandong Internet plus medical health demonstration province construction action plan" (2019-2020 years), pointed out that in 2020, a shortage of drug monitoring and early warning system will be built to start the construction of public hospital drug use monitoring system, and strive to achieve five provinces and municipalities, medicines, medical supplies procurement information sharing Recently, the notice on the monitoring and analysis of drug use in public medical and health institutions (hereinafter referred to as the notice) issued by the office of the health and Health Commission of Inner Mongolia Autonomous Region also shows that Inner Mongolia will actively respond to the relevant requirements of the national health and Health Commission, and all regions need to carry out the monitoring and analysis of drug use in medical and health institutions We will select medical and health institutions to carry out drug use monitoring and analysis according to the principle of full coverage of three-level public medical and health institutions, 50% of two-level public medical and health institutions and 10% of grass-roots public medical and health institutions In general, the country's monitoring of drug use in nearly 10000 medical institutions is only the beginning In the future, with more and more hospitals carrying out comprehensive drug use monitoring, unreasonable use of serious drugs may face a series of adjustment measures The next step for the industry is to clean the monitoring data and find out the unreasonable use of drugs, drug price differences, drug safety and other issues Therefore, in view of these problems, according to the relevant departments of the state or the introduction of more targeted policies for management, is worthy of the focus of pharmaceutical enterprises.